NSN 6505-01-501-1389
Part Details | LORAZEPAM INJECTION
6505-01-501-1389
Alternate Parts: 021482, 02-1482, NDC00409198530, NDC00409-1985-30, 6505-01-501-1389, 01-501-1389, 6505015011389, 015011389
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | SEP 25, 2002 | 01-501-1389 | 50832 ( LORAZEPAM INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-501-1389
Part Number | Cage Code | Manufacturer |
---|---|---|
02-1482 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
NDC00409-1985-30 | 3VBU6 | HOSPIRA, INC. |
Technical Data | NSN 6505-01-501-1389
Characteristic | Specifications |
---|---|
PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY2.000 MILLIGRAMS LORAZEPAM |
ADMINISTRATION | B$K OTIC IRRIGATION |
TOTAL PRIMARY CONTAINER QUANTITY | 10 |
FEATURES PROVIDED | STERILE |
SPECIAL FEATURES | 1 ML FILL IN A 2 ML CARPUJECT WITH LEUR LOCK, SLIMPAK, PREANESTHETIC MEDICATION PRODUCING SEDATION RELIEF OF ANXIETY AND A DECREASE ABILITY TO RECALL EVENT RELATED TO THE DAY OF THE SURGERY |
PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
PART NAME ASSIGNED BY CONTROLLING AGENCY | LORAZEPAM INJECTION USP 2MG/ML 1ML SYRINGE 10S |
CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |